This Article Full Text Full Text (PDF) A correction has been published Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Riis, A. L. D. Articles by Jørgensen, J. O. L. Search for Related Content PubMed PubMed Citation Articles by Riis, A. L. D. Articles by Jørgensen, J. O. L.

Hyperthyroidism Is Associated with Suppressed Circulating Ghrelin Levels

Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital (A.L.D.R., T.K.H., J.W., J.O.L.J.), and Institute of Experimental Clinical Research (N.M.), Aarhus University, 8000 Aarhus, Denmark

Address all correspondence and requests for reprints to: Dr. Anne Lene Riis, Medical Department M, Aarhus University Hospital, 8000 Arhus, Denmark. E-mail: anne.lene.riis{at}iekf.au.dk.

Ghrelin stimulates GH secretion as well as appetite and food intake. To explore whether ghrelin is involved in the regulation of appetite and body weight in hyperthyroidism, circulating ghrelin levels were measured in nine hyperthyroid patients before and after medical treatment and compared with those in eight healthy control subjects. All participants were studied in the postabsorptive state and during a 3-h euglycemic hyperinsulinemic clamp. Before treatment the patients had 3- to 5-fold elevations of T₃, and during treatment the patients gained 5 kg of body weight. Ghrelin levels were decreased in hyperthyroidism both in the fasting state (hyperthyroid, 1080 ± 195 pg/ml; euthyroid, 1480 ± 215 pg/ml; P = 0.03) and during clamp (hyperthyroid, 833 ± 150 pg/ml; euthyroid, 1210 ± 180 pg/m; P = 0.02). After treatment, ghrelin levels did not differ from those in control subjects. In all three study groups the clamp significantly reduced ghrelin levels compared with fasting levels. In conclusion, ghrelin levels are reduced in hyperthyroidism and become normalized by medical antithyroid treatment. Hyperinsulinemia suppresses ghrelin regardless of thyroid status. Ghrelin is not a primary stimulator of appetite and food intake in hyperthyroidism, and the mechanisms underlying the suppressive effect of hyperthyroidism on ghrelin secretion remain unclear.

This work was supported by grants from The Danish Health Research Council (Grant 9600822; Aarhus University-Novo Nordisk Center for Research in Growth and Regeneration), the World Anti Doping Agency, the Aarhus University Research Fund, and The Musikforlæggerne Agnes and Knut Mørks Fund.

Abbreviations: EE, Energy expenditure; FFA, free fatty acids; LBM, lean body mass; RQ, respiratory quotient.

This article has been cited by other articles:

				S. Gjedde, E. T. Vestergaard, L. C. Gormsen, A. L. D. Riis, J. Rungby, N. Moller, J. Weeke, and J. O. L. Jorgensen Serum Ghrelin Levels Are Increased in Hypothyroid Patients and Become Normalized by L-Thyroxine Treatment J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2277 - 2280. [Abstract] [Full Text] [PDF]

				D. H. St-Pierre, A. D. Karelis, L. Coderre, F. Malita, J. Fontaine, D. Mignault, M. Brochu, J.-P. Bastard, K. Cianflone, E. Doucet, et al. Association of Acylated and Nonacylated Ghrelin with Insulin Sensitivity in Overweight and Obese Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 264 - 269. [Abstract] [Full Text] [PDF]

				L. C Gormsen, J. Gjedsted, S. Gjedde, E. T. Vestergaard, J. S Christiansen, J. O. Jorgensen, S. Nielsen, and N. Moller Free fatty acids decrease circulating ghrelin concentrations in humans. Eur. J. Endocrinol., May 1, 2006; 154(5): 667 - 673. [Abstract] [Full Text] [PDF]

				C. Langenberg, J. Bergstrom, G. A. Laughlin, and E. Barrett-Connor Ghrelin and the Metabolic Syndrome in Older Adults J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6448 - 6453. [Abstract] [Full Text] [PDF]

				O. Gimenez-Palop, G. Gimenez-Perez, D. Mauricio, E. Berlanga, N. Potau, C. Vilardell, J. Arroyo, J.-M. Gonzalez-Clemente, and A. Caixas Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes Eur. J. Endocrinol., July 1, 2005; 153(1): 73 - 79. [Abstract] [Full Text] [PDF]

				Y. Nishi, H. Hiejima, H. Mifune, T. Sato, K. Kangawa, and M. Kojima Developmental Changes in the Pattern of Ghrelin's Acyl Modification and the Levels of Acyl-Modified Ghrelins in Murine Stomach Endocrinology, June 1, 2005; 146(6): 2709 - 2715. [Abstract] [Full Text] [PDF]

				D. H. St-Pierre, A. D. Karelis, K. Cianflone, F. Conus, D. Mignault, R. Rabasa-Lhoret, M. St-Onge, A. Tremblay-Lebeau, and E. T. Poehlman Relationship between Ghrelin and Energy Expenditure in Healthy Young Women J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5993 - 5997. [Abstract] [Full Text] [PDF]

				T. Y. Jeon, S. Lee, H. H. Kim, Y. J. Kim, H. C. Son, D. H. Kim, and M. S. Sim Changes in Plasma Ghrelin Concentration Immediately after Gastrectomy in Patients with Early Gastric Cancer J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5392 - 5396. [Abstract] [Full Text] [PDF]

				A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF]

				J. Erdmann, R. Topsch, F. Lippl, P. Gussmann, and V. Schusdziarra Postprandial Response of Plasma Ghrelin Levels to Various Test Meals in Relation to Food Intake, Plasma Insulin, and Glucose J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 3048 - 3054. [Abstract] [Full Text] [PDF]

				G. Murdolo, P. Lucidi, C. Di Loreto, N. Parlanti, A. De Cicco, C. Fatone, C. G. Fanelli, G. B. Bolli, F. Santeusanio, and P. De Feo Insulin is Required for Prandial Ghrelin Suppression in Humans Diabetes, December 1, 2003; 52(12): 2923 - 2927. [Abstract] [Full Text] [PDF]

				Y. Hataya, T. Akamizu, H. Hosoda, N. Kanamoto, K. Moriyama, K. Kangawa, K. Takaya, and K. Nakao Alterations of Plasma Ghrelin Levels in Rats with Lipopolysaccharide-Induced Wasting Syndrome and Effects of Ghrelin Treatment on the Syndrome Endocrinology, December 1, 2003; 144(12): 5365 - 5371. [Abstract] [Full Text] [PDF]

				J. E. Caminos, R. Nogueiras, M. Blanco, L. M. Seoane, S. Bravo, C. V. Alvarez, T. Garcia-Caballero, F. F. Casanueva, and C. Dieguez Cellular Distribution and Regulation of Ghrelin Messenger Ribonucleic Acid in the Rat Pituitary Gland Endocrinology, November 1, 2003; 144(11): 5089 - 5097. [Abstract] [Full Text] [PDF]